All News
Analysis from Rutgers connects many chronic conditions other than cancer and diabetes with medical debt.
A novel protein design could lead to a new generation of defensive biosensors and treatments against weapons of mass destruction.
When a potential remedy is worth testing and a placebo arm is needed to prove efficacy, some trial patients should get the placebo.
Rutgers research correlates substance-use patterns and personal characteristics with COVID-19 impacts.
